NCT03123185View on ClinicalTrials.gov

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

February 19, 2018

Study Completion Date

February 19, 2018

Conditions
Healthy
Interventions
DRUG

Placebo

Tablet and solution formulation

DRUG

BI 705564 (Test)

Fed state

DRUG

BI 705564 (Reference)

Fasting state

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY